1-5 of 5
Caterina Ilari
Close
Sort by
Journal Articles

Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study

Clinical Trials & Observations
Gian Matteo Rigolin, Ilaria Del Giudice, Antonella Bardi, Aurora Melandri, Rocio Edith García-Jacobo, Francesca Cura, Sara Raponi, Caterina Ilari, Luciana Cafforio, Alfonso Piciocchi, Valentina Arena, Gianluigi Reda, Francesco Albano, Stefano Molica, Paolo Sportoletti, Livio Trentin, Monia Marchetti, Mauro Nanni, Nadia Peragine, Paola Mariglia, Marco Vignetti, Anna Guarini, Francesca Romana Mauro, Robin Foà, Antonio Cuneo
Journal: Blood
Blood (2021) 138 (25): 2727–2730.
https://doi.org/10.1182/blood.2021011883
Published: 2021
Includes: Supplemental data
Journal Articles

TP53 Clonal and Subclonal Architecture in Chronic Lymphocytic Leukemia Patients Under Ibrutinib Treatment

Ilaria Del Giudice, Luciana Cafforio, Luca Vincenzo Cappelli, MD, Caterina Ilari, PhD, Sara Raponi, Maria Stefania De Propris, Paola Mariglia, Francesca Romana Mauro, Marco Vignetti, Anna Guarini, PhD, Robin Foà, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3119.
https://doi.org/10.1182/blood-2018-99-114232
Published: 2018
Journal Articles

Comparative Analysis between RQ-PCR, Digital-Droplet-PCR and Next-Generation-Sequencing (NGS) of Immunoglobulin/T-Cell Receptor Gene Rearrangements to Monitor Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia Patients

Irene Della Starza, PhD, Lucia Anna De Novi, PhD, Alessandra Santoro, PhD, Salemi Domenico, PhD, Marzia Cavalli, PhD, Roberta Soscia, Francesca Paoloni, Lucia Menale, Valerio Apicella, Caterina Ilari, PhD, Antonella Vitale, Marco Vignetti, MD, Renato Bassan, MD, Sabina Chiaretti, MD PhD, Anna Guarini, PhD, Robin Foà, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2828.
https://doi.org/10.1182/blood-2018-99-118219
Published: 2018
Journal Articles

Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study

Francesca Romana Mauro, MD PhD, Francesco Zaja, Stefano Molica, MD, Marta Coscia, MD PhD, Anna Marina Liberati, Alfonso Piciocchi, Fiorella Ilariucci, MD, Filomena Russo, MD, Francesca Re, MD, Alessandra Tedeschi, MD, Anna Baraldi, MD, Angelo Michele Carella, Alessandro Gozzetti, MD, Giovanni Del Poeta, Pr, MD, Agostino Cortelezzi, MD, Roberta Battistini, MD, Emilia Iannella, MD, Antonietta Ferretti, MD, Ilaria Del Giudice, MD PhD, Irene Della Starza, PhD, Sara Raponi, PhD, Maria Stefania De Propris, PhD, Caterina Ilari, PhD, Luciana Cafforio, PhD, Mauro Nanni, PhD, Paola Fazi, Marco Vignetti, Antonino Neri, Pr, MD, Giorgina Specchia, Pr, MD, Antonio Cuneo, Pr, MD, Anna Guarini, Robin Foà
Journal: Blood
Blood (2015) 126 (23): 2946.
https://doi.org/10.1182/blood.V126.23.2946.2946
Published: 2015
Journal Articles

BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion

Ilaria Del Giudice, MD PhD, Silvia Bonina, PhD, Marilisa Marinelli, PhD, Luciana Cafforio, Sara Raponi, PhD, Eloise Boldrini, Alexia Bonafede, Simona Tavolaro, PhD, Caterina Ilari, Monica Messina, Sabina Chiaretti, MDPhD, Francesca Romana Mauro, MD, Alfonso Piciocchi, PhD, Sonia Maria Orlando, Gian Matteo Rigolin, Antonio Cuneo, Davide Rossi, MD PhD, Gianluca Gaidano, MD PhD, Anna Guarini, PhD, Robin Foá, MD
Journal: Blood
Blood (2014) 124 (21): 3295.
https://doi.org/10.1182/blood.V124.21.3295.3295
Published: 2014